# FDA 483 - Capzer Pharmaceuticals - July 24, 2025

Source: https://www.keypedia.com/records/483/capzer-pharmaceuticals/edf9ece7-4632-42a0-b58d-cf359e1f588e

> FDA 483 for Capzer Pharmaceuticals on July 24, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Capzer Pharmaceuticals
- Inspection Date: 2025-07-24
- Product Type: drugs
- Office Name: Florida District Office
- Summary: Capzer Pharmaceuticals, a control laboratory in Lake Worth Beach, FL, was inspected by the FDA, revealing significant deficiencies. The inspection found that the firm's quality control unit lacked adequately written and followed procedures, and laboratory records were incomplete, specifically missing sample collection dates. These issues indicate a failure to adhere to established quality standards for pharmaceutical operations.

## Related Officers

- [Advisor](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/capzer-pharmaceuticals/18679996-1903-44e1-900f-29d6a2156d37

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9